Osteoporosis: Opportunity for Better Outcomes Faculty: Felicia Cosman, MD | Nelson B. Watts, MD | Michael R. McClung, MD | Kenneth W. Lyles, MD
CME credit hours: 2.0
Osteoporotic fractures affect millions of postmen-opausal women, and can have a substantial negative effect on daily functioning and quality of life. These fractures are associated with an increased risk of future fracture, clinical complications, and a higher risk of death. However, osteoporosis remains woefully under-diagnosed and undertreated, even among patients who already have fractures. When treatment is provided, adherence and persistence are often suboptimal, reducing the likelihood of a positive outcome.
Applying Principles to Practice in the Treatment of Osteoporosis
Faculty: John P. Bilezikian, MD, FACP, MACE | E. Michael Lewiecki, MD, FACP | Paul D. Miller, MD, FACP
CME Credit hour: 1.5
The role of the clinician in the prevention, assessment, diagnosis, and treatment of osteoporosis is well established; however, osteoporosis remains underdiagnosed and undertreated. As a result, it is imperative for clinicians in all specialties to screen for and treat osteoporosis to prevent fractures and reduce burden of disease. This program will discuss barriers to providing optimal osteoporosis care and explore how alternative routes of administration can improve outcomes for patients with osteoporosis.
Optimizing Outcomes for Patients With Metabolic Bone Disease (Accreditation Expired)
Faculty: Steven T. Harris, MD, FACP | Frederick R. Singer, MD | Graham Russell, MD, PhD
CME Credit hour: 1.0
The goal of this program is to offer healthcare professionals the opportunity to review the latest clinical data and approaches in the management of osteoporosis and Paget’s disease of bone.
The Evolving Management of Bone Disease: Changes on the Horizon (Accreditation Expired)
Faculty: Ethel S. Siris, MD | Jacques P. Brown, MD, FRCP | John A. Kanis, BSc, MB ChB, MD, FRCP, FRCPath | R. Graham Russell, MD, PhD
CME Credit hour: 1.0
The goal of this program is to offer healthcare professionals the opportunity to review the latest clinical data and approaches in the management of metabolic bone disease.